Monocyte locomotion inhibitory factor
US6524591B1 · kind B1 · utility
5Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 29, 1999 |
| Grant date | Feb 25, 2003 |
| Priority date | — |
| Expiry date | Jun 29, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an anti-inflammatroy oligopeptide which can be obtained from the microorganism Entamoeba histolytica or synthesized by known methods. The oligopeptides are useful in treating inflammatory diseases when formulated in pharmaceutical compositions for administration to patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.